Enhanced delivery of exogenous peptides into the class I antigen processing and presentation pathway.
Lolke De Haan, Arron R Hearn, A Jennifer Rivett, Timothy R Hirst
Index: Infect. Immun. 70(6) , 3249-58, (2002)
Full Text: HTML
Abstract
Current immunization strategies, using peptide or protein antigens, generally fail to elicit cytotoxic-T-lymphocyte responses, since these antigens are unable to access intracellular compartments where loading of major histocompatibility complex class I (MHC-I) molecules occurs. In an attempt to circumvent this, we investigated whether the GM1 receptor-binding B subunit of Escherichia coli heat-labile toxin (EtxB) could be used to deliver class I epitopes. When a class I epitope was conjugated to EtxB, it was delivered into the MHC-I presentation pathway in a GM1-binding-dependent fashion and resulted in the appearance of MHC-I-epitope complexes at the cell surface. Importantly, we show that the efficiency of EtxB-mediated epitope delivery could be strikingly enhanced by incorporating, adjacent to the class I epitope, a 10-amino-acid segment from the C terminus of the DNA polymerase (Pol) of herpes simplex virus. The replacement of this 10-amino-acid segment by a heterologous sequence or the introduction of specific amino acid substitutions within this segment either abolished or markedly reduced the efficiency of class I epitope delivery. If the epitope was extended at its C terminus, EtxB-mediated delivery into the class I presentation pathway was found to be completely dependent on proteasome activity. Thus, by combining the GM1-targeting function of EtxB with the 10-amino-acid Pol segment, highly efficient delivery of exogenous epitopes into the endogenous pathway of class I antigen processing and presentation can be achieved.
Related Compounds
Related Articles:
2015-04-01
[Biomed. Microdevices 17(2) , 39, (2015)]
A chitosan coated monolith for nucleic acid capture in a thermoplastic microfluidic chip.
2014-07-01
[Biomicrofluidics 8(4) , 044109, (2014)]
Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model.
2014-12-15
[Oncotarget 5(23) , 12383-97, (2015)]
2014-08-01
[Anticancer Res. 34(8) , 4521-7, (2014)]
Comparison of antibody functionality using different immobilization methods.
2003-10-20
[Biotechnol. Bioeng. 84(2) , 215-23, (2003)]